1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Clinical and radiologic characteristics in the hyperglycemic and nonhyperglycemic groups
Hyperglycemic Patients (n = 34) Nonhyperglycemic Patients (n = 60) P Value Age (yr) 60 62 .65 57–61 55–67 Thrombolytic treatment (%) 74 63 .38 Baseline NIHSS score 17 14 .003 15–20 11–16 Baseline SGL (mmol/L) 8.7 5.8 <.0001 7.8–10.9 5.4–6.2 Time to initial MRI (min) 132 150 .22 112–157 128–176 Time to follow-up MRI (hr) 32 28 .13 26.5–45.7 23–37.3 Recanalized patients (n, %) 23 44 .70 68% 72% Initial DWI volume (cm3) 29 18.3 .08 7.9, 47.5 16.6, 55.3 Mean ADC in initial DWI vol (× 10−6 mm2/s) 652 633 .56 609–694 580–674 Final DWI volume (cm3) 74.5 31.8 .004 34.8, 134.1 20.4, 57 Predicted final volume (cm3) 50.5 39.7 .25 21.3, 123.8 15.9, 82.2 Predicted infarct growth (cm3) 29.3 23.5 .47 (0.9, 53.3) (5.4, 44.5) Observed infarct growth (cm3) 40.2 9.2 .0003 (10.6, 85) (3.2, 30.8) Spared tissue-at-risk (cm3) −5.9 7 .0025 −55.1, 8.5 −3.6, 25.2
Note:Numbers are shown as the median and interquartile range.